Navigation Links
Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
Date:3/1/2013

WELWYN GARDEN CITY, England and BOSTON, March 1, 2013 /PRNewswire/ --

Heptares Therapeutics, the leading GPCR drug discovery company, announces that Malcolm Weir (Heptares CEO) will attend the 6th Annual European Life Science CEO Forum  taking place on the at the Hilton Zurich Airport Hotel, Zurich, Switzerland (5-6 March), at which he will participate in a panel discussion on Platform Technologies and Novel Therapeutics (2:00pm-3:15pm, 5 March). Dr Weir will also present an overview of the company at the event (5 March, 11:45am in Panorama B).

Dr Weir and Barry Kenny (Chief Business Officer) will also attend BIO-Europe Spring 2013 at the CCIB Convention Centre, Barcelona, Spain (11-13 March).

For a full list of events at which Heptares will be present, please visit http://www.heptares.com

About Heptares Therapeutics

Heptares creates new medicines targeting clinically important, yet historically challenging, GPCRs (G protein-coupled receptors), a superfamily of drug receptors linked to a wide range of human diseases. Leveraging our advanced structure-based drug design technology platform, we have built an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including Alzheimer's disease, Parkinson's disease, schizophrenia, migraine and diabetes. Our pharmaceutical partners include Shire, Cubist, Takeda, MorphoSys, AstraZeneca and MedImmune, and we are backed by MVM Life Science Partners, Clarus Ventures, Novartis Venture Fund and Takeda Ventures. To learn more about Heptares, please visit http://www.heptares.com.


'/>"/>
SOURCE Heptares Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Heptares and UK Medical Research Council Extend GPCR Collaboration
2. Heptares to Present at 5th CNS Partnering and Deal-Making Conference (13-14 SEPTEMBER)
3. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
4. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
7. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
9. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
10. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
11. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... and PUNE, India , ... a new report published by Allied Market Research, titled, ... Opportunity Analysis and Industry Forecast, 2014-2022," the global sterilization ... 2022, from $5,768 million in 2015, growing at a ... & gas sterilization segment dominated the market in 2015, ...
(Date:1/16/2017)... Jan. 16, 2017   Linde Gas North America LLC ... assets and business of The Service Center LLC, a market ... to healthcare providers in the Midwest and Southeast regions of ... Illinois , The Service Center also has facilities in ... South Carolina . Its primary services include: ...
(Date:1/16/2017)... FRANCISCO, Calif. , Jan. 16, 2017  Rigel ... on January 3, 2017 and January 16, 2017 the ... grant of inducement stock options to purchase an aggregate ... employees. These awards were granted pursuant to the Rigel ... material to the new employees entering into employment with ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s ... Victor Giamos, MD to their medical staff, according to eye surgeon, Jeffrey Martin, ... Eye Care, a division of SightMD. Dr. Giamos will practice primarily out of ...
(Date:1/16/2017)... ... 2017 , ... Specialty Technical Publishers (STP) and Specialty Technical ... (IAPC) EHS audit protocol for Singapore . Leading companies around the world ... obligations and rapidly collect, share, archive, and export audit findings in a cost ...
(Date:1/16/2017)... ... , ... St. Louisans are well-aware of the following facts at present:, ... to be having no effect on keeping this particularly bad strain of the flu away ... coughing, sneezing, or sniffling , These facts are well-known among the team ...
(Date:1/16/2017)... ... January 16, 2017 , ... Board-certified oculoplastic surgeon Dr. Mehryar ... official journal of The American Society for Aesthetic Plastic Surgery, in which he ... designed to correct drooping, retracted lower eyelids, which usually result from genetics, injury, ...
(Date:1/16/2017)... PARK CITY, UT (PRWEB) , ... January 16, 2017 , ... ... expensive disease not only to treat, but to test for, as well. The money ... $88.7 billion every year.(1) Doctors in the U.S. screen patients for cancer more than ...
Breaking Medicine News(10 mins):